Overall rank by patents
#9,278
Across all tracked assignees
USPTO PatentsView assignee record - 34 granted patents across 6 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).
The verdict
Henke-sass holds 34 US patents across 6 technology areas, rank #9,278 of 50,000 tracked assignees.
Henke-sass, Wolf Gmbh has been granted 34 US utility patents between 2015 and 2025, placing Henke-sass, Wolf Gmbh at rank #9,278 across all assignees tracked by PlainPatent. This portfolio spans 6 distinct Cooperative Patent Classification (CPC) subclasses, averaging 10.5 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a Foreign Corporation, Henke-sass, Wolf Gmbh is one of the more focused assignees in the PatentsView dataset. By volume, Henke-sass sits between Harris Global Communications, Inc. (34 patents, rank #9,274) and Hyland UK Operations Limited (34 patents, rank #9,282) - the closest US assignees by grant volume. The composite Innovation Score of 29.0/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 16 grants, compared with 18 in the 2015–2019 window, a -11% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Henke-sass, Wolf Gmbh's 10.5 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while concentration in 6 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Henke-sass, Wolf Gmbh against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
HARRIS GLOBAL COMMUNICATIONS, INC.
34 patents
HIGHLIFE SAS
34 patents
HORIBA INSTRUMENTS INCORPORATED
34 patents
HS MARSTON AEROSPACE LIMITED
34 patents
Heron Therapeutics, Inc.
34 patents
Hublot SA, Genève
34 patents
Huf North America Automotive Parts Manufacturing Corp.
34 patents
Hyland UK Operations Limited
34 patents
Henke-Sass, Wolf GmbH
34 patents
What this shows Henke-sass holds 34 patents at rank #9,278, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #9,278 in granted patent volume.
Other assignees with the most granted patents in Henke-sass's primary technology class.
Henke-sass's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
29 Top 71% higher than 29% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 2 | 5.9% |
| 2016 | 4 | 11.8% |
| 2017 | 2 | 5.9% |
| 2018 | 5 | 14.7% |
| 2019 | 5 | 14.7% |
| 2020 | 2 | 5.9% |
| 2021 | 4 | 11.8% |
| 2022 | 3 | 8.8% |
| 2025 | 7 | 20.6% |
Top 6 of 6 technology areas
Overall rank by patents
#9,278
Across all tracked assignees
29.0 out of 100
How to use this portfolio
Henke-sass's 34 grants land it in the top 71% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.